Catalysts for Avyxa Pharma LLC
11 tracked
Feb 20, 2026
approval
FAVLYXA (FLUOROURACIL) — FDA approval
Efudex
→
Feb 13, 2026
approval
AVOPEF (ETOPOSIDE) — FDA approval
etoposide
→
Feb 3, 2026
approval
VYKOURA (LEUCOVORIN CALCIUM) — FDA approval
LEUCOVORIN CALCIUM
→
Nov 21, 2025
approval
FULVESTRANT — FDA approval
FULVESTRANT
→
Oct 3, 2025
approval
AXTLE (PEMETREXED DIPOTASSIUM) — FDA approval
AXTLE
→
Jun 18, 2025
approval
AXTLE (PEMETREXED DIPOTASSIUM) — FDA approval
AXTLE
→
Dec 2, 2024
approval
AXTLE (PEMETREXED DIPOTASSIUM) — FDA approval
AXTLE
→
Jun 28, 2024
approval
AXTLE (PEMETREXED DIPOTASSIUM) — FDA approval
AXTLE
→
Nov 12, 2021
approval
FULVESTRANT — FDA approval
FULVESTRANT
→
Apr 6, 2021
approval
FULVESTRANT — FDA approval
FULVESTRANT
→
Aug 19, 2019
approval
FULVESTRANT — FDA approval
FULVESTRANT
→